Certificate of Analysis Each batch is tested by an independent third-party laboratory for: Peptide identity verification Purity analysis via HPLC (99%) Microbial contaminant screening Heavy metal analysis Residual solvent testing Description FOXO4-DRI is a D-retro-inverso peptide designed to interfere with the FOXO4-p53 interaction, supplied as a lyophilized 10mg vial
Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimers disease
The Skinny Set: Amino Blend + Methylcobalamin Injections Designed to complement post-weight-loss wellness, the Skinny Set combines Olympias Amino Blend and methylcobalamin to help support metabolic balance, energy levels and physical performance
Research Use Only AHK-Cu has not been evaluated by the FDA for safety or efficacy in humans
There is limited data on the effectiveness and safety of many of these products, but they have become increasingly popular, promoted by online influencers and health secretary Robert F
Published in Pharmaceuticals (PMID: 38675421), this 41-page open-access review proposes that BPC-157, while not meeting classical neurotransmitter criteria, functions as a cytoprotection mediator with neurotransmitter-like activity through a network of interconnected evidence. What Makes BPC-157 Unique BPC-157 is a 15-amino acid peptide (sequence: GEPPPGKPADDAGLV, molecular weight 1419) native and stable in human gastric juice for over 24 hours, showing no sequence homology with known gut peptides